Most GLP-1a weight loss and type diabetes medications require a prior authorization (PA) from the insurance provider: FDA-approved weight loss medications: Contrave, Saxenda (liraglutide), Wegovy (semaglutide) Zepbound (tirzepatide) FDA-approved Diabetes medications: Rybelsis, Victoza (liraglutide), Ozempic (semaglutide), or Mounjaro (tirzepatide) If your insurance company says that they cover FDA-approved diabetes medications, it suggests coverage for patients with type 2 diabetes
Is it improving, stable, or becoming worse
Coester, B., Foll, C
Conversely, antagonizing amylin receptors leads to an increase in adipose tissue [95]
Circulating sDPP-4 is increased in obesity and insulin resistance but is not related to systemic metabolic inflammation
This is important context when managing expectations of results from taking GLP-1s as well as addressing the internalized weight bias that many of us hold after marinating in diet and weight-biased medical culture